TLR4 and neoplasm: In this study, paclitaxel/ATP release induced the inflammasome activation via TLR4 that led to the phosphorylation of IkB and Jun N-terminal kinase (JNK) and the upregulation of pro-inflammatory cytokines [14] in favor of tumor growth.